These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 9664905

  • 21. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R, Perle MA, Inghirami G, Chan W, Delgado Y, Feiner H.
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer.
    Kenny FS, Hui R, Musgrove EA, Gee JM, Blamey RW, Nicholson RI, Sutherland RL, Robertson JF.
    Clin Cancer Res; 1999 Aug; 5(8):2069-76. PubMed ID: 10473088
    [Abstract] [Full Text] [Related]

  • 29. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.
    Zukerberg LR, Yang WI, Gadd M, Thor AD, Koerner FC, Schmidt EV, Arnold A.
    Mod Pathol; 1995 Jun; 8(5):560-7. PubMed ID: 7675778
    [Abstract] [Full Text] [Related]

  • 30. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast.
    Oyama T, Kashiwabara K, Yoshimoto K, Arnold A, Koerner F.
    Cancer Res; 1998 Jul 01; 58(13):2876-80. PubMed ID: 9661905
    [Abstract] [Full Text] [Related]

  • 31. [Correlation among expression of E-cadherin, beta-catenin, and cyclin D1 in breast cancers].
    Yang JF, Chen SL, Liu ZH, Zhang Y.
    Ai Zheng; 2004 Jul 01; 23(7):799-802. PubMed ID: 15248915
    [Abstract] [Full Text] [Related]

  • 32. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
    Wang L, Hoque A, Luo RZ, Yuan J, Lu Z, Nishimoto A, Liu J, Sahin AA, Lippman SM, Bast RC, Yu Y.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3660-6. PubMed ID: 14506155
    [Abstract] [Full Text] [Related]

  • 33. Immunohistochemical staining for cyclin D1 and Ki-67 aids in the stratification of atypical ductal hyperplasia diagnosed on breast core biopsy.
    Hameed O, Ghali VS, Tartter PI, Mizrachi H.
    Am J Clin Pathol; 2005 Dec 01; 124(6):862-72. PubMed ID: 16416735
    [Abstract] [Full Text] [Related]

  • 34. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
    Tezel GG, Uner A, Yildiz I, Guler G, Takahashi M.
    Pathol Res Pract; 2009 Dec 01; 205(6):403-8. PubMed ID: 19232840
    [Abstract] [Full Text] [Related]

  • 35. Abnormal expression of cell cycle regulatory proteins in ductal and lobular carcinomas of the breast.
    Geradts J, Ingram CD.
    Mod Pathol; 2000 Sep 01; 13(9):945-53. PubMed ID: 11007034
    [Abstract] [Full Text] [Related]

  • 36. Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast.
    Gonzalez LO, Corte MD, Junquera S, Bongera M, Rodriguez JC, Vizoso FJ.
    Histopathology; 2007 Jun 01; 50(7):866-74. PubMed ID: 17543076
    [Abstract] [Full Text] [Related]

  • 37. Histological category and expression of hormone receptors in ductal carcinoma in situ of the breast.
    Lebrecht A, Buchmann J, Hefler L, Lampe D, Koelbl H.
    Anticancer Res; 2002 Jun 01; 22(3):1909-11. PubMed ID: 12168892
    [Abstract] [Full Text] [Related]

  • 38. Different proliferative patterns characterize different preinvasive breast lesions.
    Viacava P, Naccarato AG, Bevilacqua G.
    J Pathol; 1999 Jul 01; 188(3):245-51. PubMed ID: 10419590
    [Abstract] [Full Text] [Related]

  • 39. Cyclin D1 expression in ductal carcinoma of the breast and its correlation with other prognostic parameters.
    Ravikumar G, Ananthamurthy A.
    J Cancer Res Ther; 2014 Jul 01; 10(3):671-5. PubMed ID: 25313758
    [Abstract] [Full Text] [Related]

  • 40. Regional cyclin D1 overexpression or hypoxia correlate inversely with heterogeneous oestrogen receptor-alpha expression in human breast cancer.
    Kronblad A, Helczynska K, Nielsen NH, Påhlman E, Emdin S, Påhlman S, Landberg G.
    In Vivo; 2003 Jul 01; 17(4):311-8. PubMed ID: 12929585
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.